Literature DB >> 11899279

Allergenic components of vaccines and avoidance of vaccination-related adverse events.

J W Georgitis1, M B Fasano.   

Abstract

Vaccines have had a dramatic effect on the prevalence of communicable diseases, but, in selected individuals, the injection presents a risk of anaphylaxis. Fortunately, most people have no allergic reactions to vaccines. In egg-allergic individuals, care must be taken before administering specific vaccines; the algorithm provided in this article gives specific recommendations for skin testing and desensitization. This algorithm is not needed for individuals receiving the measles-mumps-rubella vaccine because the risk of anaphylaxis is extremely low, even in those with known egg-protein sensitivity. Some individuals have gelatin sensitivity, which may cause anaphylaxis. Selected vaccines contain antibiotic drugs, so it is important to note if an individual has any known drug sensitivity, especially to neomycin, polymyxin B, or amphotericin B. Lastly, vaccine preservatives may cause reactions, but this occurs very infrequently.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899279     DOI: 10.1007/s11882-001-0091-6

Source DB:  PubMed          Journal:  Curr Allergy Rep


  14 in total

1.  Public health. Aluminum is put on trial as a vaccine booster.

Authors:  D Malakoff
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

2.  IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines.

Authors:  M Sakaguchi; S Inouye
Journal:  Vaccine       Date:  2000-04-03       Impact factor: 3.641

3.  Complications of immunizations.

Authors:  R Agha
Journal:  Pediatr Rev       Date:  1997-02

4.  Vaccine adverse events reported in New Zealand 1990-5.

Authors:  O Mansoor; P I Pillans
Journal:  N Z Med J       Date:  1997-07-25

5.  Aluminum content of vaccines used in Turkey.

Authors:  T Baydar; A Aydin; A Isimer; G Kanra; G Sahin
Journal:  J Trace Elem Med Biol       Date:  1999-07       Impact factor: 3.849

6.  Sensitization to thimerosal in atopic children.

Authors:  A Patrizi; L Rizzoli; C Vincenzi; P Trevisi; A Tosti
Journal:  Contact Dermatitis       Date:  1999-02       Impact factor: 6.600

Review 7.  Safe administration of the measles vaccine to children allergic to eggs.

Authors:  J M James; A W Burks; P K Roberson; H A Sampson
Journal:  N Engl J Med       Date:  1995-05-11       Impact factor: 91.245

8.  Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein.

Authors:  J J Herman; R Radin; R Schneiderman
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

9.  Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.

Authors:  J M Kelso; R T Jones; J W Yunginger
Journal:  J Allergy Clin Immunol       Date:  1993-04       Impact factor: 10.793

10.  North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens.

Authors:  J G Marks; D V Belsito; V A DeLeo; J F Fowler; A F Fransway; H I Maibach; C G Mathias; J R Nethercott; R L Rietschel; E F Sherertz; F J Storrs; J S Taylor
Journal:  J Am Acad Dermatol       Date:  1998-06       Impact factor: 11.527

View more
  3 in total

1.  Effects of body weight on antibody titers against canine parvovirus type 2, canine distemper virus, and canine adenovirus type 1 in vaccinated domestic adult dogs.

Authors:  Masayuki Taguchi; Kazuhiko Namikawa; Takuya Maruo; Miyoko Saito; Jonathan Lynch; Hiroeki Sahara
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

2.  Vaccination in children with allergy to non active vaccine components.

Authors:  Fabrizio Franceschini; Paolo Bottau; Silvia Caimmi; Giuseppe Crisafulli; Liotti Lucia; Diego Peroni; Francesca Saretta; Mario Vernich; Carlotta Povesi Dascola; Carlo Caffarelli
Journal:  Clin Transl Med       Date:  2015-02-14

3.  Large-scale survey of adverse reactions to canine non-rabies combined vaccines in Japan.

Authors:  Kazuki Miyaji; Aki Suzuki; Hidekatsu Shimakura; Yukari Takase; Akio Kiuchi; Masato Fujimura; Goro Kurita; Hajime Tsujimoto; Masahiro Sakaguchi
Journal:  Vet Immunol Immunopathol       Date:  2012-01-04       Impact factor: 2.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.